Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

PURPOSE: To update the ASCO clinical practice guideline on adjuvant endocrine therapy on the basis of emerging data on the optimal duration of treatment, particularly adjuvant tamoxifen. METHODS: ASCO convened the Update Committee and conducted a systematic review of randomized clinical trials from...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Autores principales: Burstein, Harold J., Temin, Sarah, Anderson, Holly, Buchholz, Thomas A., Davidson, Nancy E., Gelmon, Karen E., Giordano, Sharon H., Hudis, Clifford A., Rowden, Diana, Solky, Alexander J., Stearns, Vered, Winer, Eric P., Griggs, Jennifer J.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2014
Materias:
ASCO Special Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4876310/
https://ncbi.nlm.nih.gov/pubmed/24868023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.54.2258
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares